Semma Therapeutics

Acquired

Semma Therapeutics is a biotech company in Cambridge, United States, founded in 2014. It has 2 recorded funding rounds, most recently a Series B in November 2017.

Employees
11–50
Founded
2014
Business Model
B2B
Last Round
Series BNov 2017
Rounds
2
Acquired by
Vertex PharmaceuticalsSep 2019

Indexed holds 2 funding rounds and 13 investors for this company. The full record is or through the API.

About

Semma Therapeutics was a Cambridge, Massachusetts-based biotechnology company founded in 2014 by Harvard stem cell biologist Douglas Melton. The company pioneered the use of stem cell-derived human islets as a potentially curative treatment for type 1 diabetes. Semma raised $158 million before being acquired by Vertex Pharmaceuticals in 2019 for $950 million.

Summary

It lists 11–50 employees. Its most recent funding was a Series B round in Nov 2017. Investors include MPM Capital, Vertex Pharmaceuticals and Eight Roads Ventures.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionSep 2019

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Semma Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/semma-therapeutics"><img src="https://indexed.vc/api/badge/company/semma-therapeutics" alt="Semma Therapeutics on Indexed.vc" width="260" height="76" /></a>